Aimery de Gramont

Aimery de Gramont

UNVERIFIED PROFILE

Are you Aimery de Gramont?   Register this Author

Register author
Aimery de Gramont

Aimery de Gramont

Publications by authors named "Aimery de Gramont"

Are you Aimery de Gramont?   Register this Author

100Publications

3727Reads

39Profile Views

Prognostic factors in patients with stage II colon cancer: Role of E-selectin gene polymorphisms.

Dig Liver Dis 2019 Aug 18;51(8):1198-1201. Epub 2019 Jun 18.

Department of Medical Oncology, Hôpital Claude Huriez, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.dld.2019.05.019DOI Listing
August 2019

Combinations of Bevacizumab and Erlotinib Show Activity in Colorectal Cancer Independent of Status.

Clin Cancer Res 2018 06 28;24(11):2548-2558. Epub 2018 Feb 28.

Cancer Biology and Therapeutics, Centre de Recherche Saint-Antoine (CRSA), Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-17-3187DOI Listing
June 2018

Three Versus 6 Months of Oxaliplatin-Based Adjuvant Chemotherapy for Patients With Stage III Colon Cancer: Disease-Free Survival Results From a Randomized, Open-Label, International Duration Evaluation of Adjuvant (IDEA) France, Phase III Trial.

J Clin Oncol 2018 05 5;36(15):1469-1477. Epub 2018 Apr 5.

Thierry André and Benoist Chibaudel, Hôpital Saint-Antoine, Assistance Publique-Hôpitaux de Paris; Thierry André, Sorbonne Universités, UMPC Paris 06; Marine Hug de Larauze and Benoist Chibaudel and Thierry André, Groupe Coopérateur Multidisciplinaire en Oncologie (GERCOR); Christophe Louvet, Institut Mutualiste Montsouris; Céline Lepère, Hôpital Européen Georges Pompidou (HEGP); Gaël Deplanque, Groupe Hospitalier Saint-Joseph; Jean-Baptiste Bachet, Groupe Hospitalier Pitié Salpêtrière and Sorbonne Université, UMPC Paris 06; Ahmed Khalil, Hôpital Tenon; Julien Taieb, Hôpital Européen Georges Pompidou and Sorbonne Paris Cité, Université Paris Descartes, Paris; Julien Taieb, Fédération Française de Cancérologie Digestive; Jeremie Bez, Fédération Française de Cancérologie Digestive; François Ghiringhelli, Centre Georges-François Leclerc, Dijon; Dewi Vernerey and Sophie Paget-Bailly, CHU de Besançon; Serge Fratte, Hôpital de Besançon; Sophie Paget-Bailly, Franck Bonnetain and Dewi Vernerey INSERM UMR1098, Besançon; Laurent Mineur, Institut Sainte Catherine, Avignon; Jaafar Bennouna, Institut de Cancérologie de l'Ouest René Gauducheau, Saint-Herblain et Institut de Cancérologie Paul Papin, Angers; Jérôme Desrame, Hôpital Jean Mermoz, Lyon; Roger Faroux, Centre Hospitalier Départemental de La Roche sur Yon, La Roche sur Yon; Serge Fratte, Hôpital of Belfort-Montbeliard, Montbeliard; Jérôme Dauba, Centre Hospitalier Layné, Mont-de-Marsan; Olivier Dupuis, Clinique Victor Hugo, Le Mans; Yves Becouran, Institut Bergonié, Bordeaux; May Mabro, Hôpital Foch, Suresnes; Joëlle Egreteau, Centre Hospitalier de Bretagne Sud Site de Lorient, Lorient; Olivier Bouche, Hôpital Robert Debré, Reims; Marc Ychou, Institut du Cancer de Montpellier, and CHU de Montpellier, Montpellier; Marie Pierre Galais, Centre Francois Baclesse, Caen; Louis Marie Dourthe, Clinique Sainte Anne, Strasbourg; and Aimery de Gramont, Institut Hospitalier Franco-Britannique, Levallois-Perret, France.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2017.76.0355
Publisher Site
http://dx.doi.org/10.1200/JCO.2017.76.0355DOI Listing
May 2018

Co-targeting poly(ADP-ribose) polymerase (PARP) and histone deacetylase (HDAC) in triple-negative breast cancer: Higher synergism in BRCA mutated cells.

Biomed Pharmacother 2018 Mar 20;99:543-551. Epub 2018 Feb 20.

Division of Hematology and Oncology, Cedars-Sinai Medical Center, UCLA School of Medicine, Los Angeles, CA, United States; National Cancer Institute and Cancer Science Institute, National University of Singapore, Singapore.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.biopha.2018.01.045DOI Listing
March 2018

Efficacy of a sequential treatment strategy with GEMOX-based followed by FOLFIRI-based chemotherapy in advanced biliary tract cancers.

Acta Oncol 2016 Sep - Oct;55(9-10):1168-1174. Epub 2016 Jun 22.

a Department of Medical Oncology , Beaujon University Hospital, Assistance Publique-Hôpitaux De Paris (AP-HP) , Clichy , France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/0284186X.2016.1191670DOI Listing
January 2018

Clinical Calculator for Early Mortality in Metastatic Colorectal Cancer: An Analysis of Patients From 28 Clinical Trials in the Aide et Recherche en Cancérologie Digestive Database.

J Clin Oncol 2017 Jun 17;35(17):1929-1937. Epub 2017 Apr 17.

Lindsay A. Renfro, Axel Grothey, and Daniel J. Sargent, Mayo Clinic, Rochester, MN; Richard M. Goldberg, The Ohio State University, Columbus, OH; Alberto Sobrero, Ospedale San Martino, Genoa; Alfredo Falcone, University Hospital of Pisa, Pisa, Italy; Richard Adams, Cardiff University, Cardiff; Matthew T. Seymour, St James's Hospital and University of Leeds, Leeds, United Kingdom; Volker Heinemann, University of Munich, Munich; Hans-Joachim Schmoll, University Clinic Halle (Saale), Halle; Rainer Porschen, Klinikum Bremen-Ost Klinik für Innere Medizin, Bremen; Carsten Bokemeyer, University Hospital, Hamburg-Eppendorf, Germany; Jean-Yves Douillard, Centre René Gauducheau, Nantes; Christophe Tournigand, University of Paris Est Creteil; Christophe Tournigand, Assistance Hopitaux Publique de Paris Henri-Mondor Hospital, Créteil; Benoist Chibaudel and Aimery de Gramont, Franco-British Institute, Levallois-Perret, France; Herbert Hurwitz, Duke University Medical Center, Durham, NC; Charles S. Fuchs; Dana-Farber Cancer Institute, Boston, MA; Eduardo Diaz-Rubio, Hospital Clínico San Carlos, Universidad Complutense, Instituto de Investigación Sanitaria del Hospital Clínico San Carlos, Madrid, Spain; Paulo M. Hoff, Hospital Sírio-Libanês and University of São Paulo, São Paulo, Brazil; Fairooz F. Kabbinavar and J. Randolph Hecht, David Geffen School of Medicine at University of California at Los Angeles, Los Angeles, CA; Niall C. Tebbutt, Austin Health, Heidelberg, Victoria, Australia; Cornelis J.A. Punt, University of Amsterdam, Amsterdam, the Netherlands; John Souglakos, University of Crete, Heraklion, Greece; Eric Van Cutsem, University Hospital Leuven, Leuven, Belgium; and Leonard Saltz, Memorial Sloan Kettering Cancer Center, New York, NY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.71.5771DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5466009PMC
June 2017

Improving Outcomes in Patients with CRC: The Role of Patient Reported Outcomes-An ESDO Report.

Cancers (Basel) 2017 May 26;9(6). Epub 2017 May 26.

Department of Internal Medicine, University Hospital Ulm, 89081 Ulm, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/cancers9060059DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5483878PMC
May 2017

BRAF-Mutated Colorectal Cancer: What Is the Optimal Strategy for Treatment?

Curr Treat Options Oncol 2017 02;18(2)

Department of Medical Oncology, Saint-Antoine Hospital, APHP, 184 rue du Faubourg Saint-Antoine, 75012, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11864-017-0453-5DOI Listing
February 2017

Ribociclib for HR-Positive, Advanced Breast Cancer.

N Engl J Med 2017 01;376(3):288-289

Institut Hospitalier Franco-Britanique, Levallois-Perret, France

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMc1615255DOI Listing
January 2017

Determinants of Early Mortality Among 37,568 Patients With Colon Cancer Who Participated in 25 Clinical Trials From the Adjuvant Colon Cancer Endpoints Database.

J Clin Oncol 2016 Apr 8;34(11):1182-9. Epub 2016 Feb 8.

Winson Y. Cheung, British Columbia Cancer Agency, Vancouver, British Columbia; Chris O'Callaghan, Queen's University, Kingston, Ontario, Canada; Lindsay A. Renfro, Axel Grothey, Steven R. Alberts, and Daniel J. Sargent, Mayo Clinic, Rochester, MN; David Kerr, University of Oxford, Oxford; Chris Twelves, University of Leeds and St James Institute of Oncology, Leeds, United Kingdom; Aimery de Gramont, Franco-British Institute, Levallois-Perret; Thierry Andre, Hospital Saint-Antoine and Pierre and Marie Curie University, Paris; Jean-Francois Seitz, La Timone Hospital, Aix-Marseille University, Marseille, France; Leonard B. Saltz, Memorial Sloan Kettering Cancer Center, New York, NY; Katherine A. Guthrie, Fred Hutchinson Cancer Center, Seattle, WA; Roberto Labianca, Ospedale Giovanni XXIII, Bergamo; Guido Francini, University of Siena, Siena, Italy; Eric Van Cutsem, University Hospital Leuven, Leuven, Belgium; Daniel G. Haller, University of Pennsylvania, Philadelphia; and Greg Yothers, University of Pittsburgh, Pittsburgh, PA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.65.1158DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4933130PMC
April 2016

Impact of Patient Factors on Recurrence Risk and Time Dependency of Oxaliplatin Benefit in Patients With Colon Cancer: Analysis From Modern-Era Adjuvant Studies in the Adjuvant Colon Cancer End Points (ACCENT) Database.

J Clin Oncol 2016 Mar 25;34(8):843-53. Epub 2016 Jan 25.

Manish A. Shah, Weill Cornell Medical College, New York/Presbyterian Hospital, New York, NY; Lindsay A. Renfro, Steven R. Alberts, and Daniel J. Sargent, Mayo Clinic, Rochester, MN; Carmen J. Allegra, University of Florida, Gainesville, FL; Thierry André, Hôpital Saint Antoine, Paris; Aimery de Gramont, Franco-British Institute, Levallois-Perret, France; Hans-Joachim Schmoll, University Clinic Halle (Saale), Halle, Germany; Daniel G. Haller, University of Pennsylvania, Philadelphia; and Greg Yothers, National Surgical Adjuvant Breast and Bowel Project, Pittsburgh, PA.

View Article

Download full-text PDF

Source
http://jco.ascopubs.org/content/early/2016/01/21/JCO.2015.63
Web Search
http://jco.ascopubs.org/cgi/doi/10.1200/JCO.2015.63.0558
Publisher Site
http://dx.doi.org/10.1200/JCO.2015.63.0558DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4872008PMC
March 2016

Chemoradiotherapy with FOLFOX plus cetuximab in locally advanced oesophageal cancer: The GERCOR phase II trial ERaFOX.

Eur J Cancer 2016 Mar 2;56:115-121. Epub 2016 Feb 2.

Groupe Coopérateur Multidisciplinaire en Oncologie (GERCOR), Paris, France; Medical Oncology Department, Saint-Antoine Universitary Hospital, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2015.12.020DOI Listing
March 2016

New Therapeutic Opportunities Based on DNA Mismatch Repair and BRAF Status in Metastatic Colorectal Cancer.

Curr Oncol Rep 2016 Mar;18(3):18

Department of Medical Oncology, Hospital Saint-Antoine, Assistance publique-Hôpitaux de Paris, 184, rue du Faubourg-Saint-Antoine, 75012, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11912-016-0504-2DOI Listing
March 2016

Body Mass Index Is Prognostic in Metastatic Colorectal Cancer: Pooled Analysis of Patients From First-Line Clinical Trials in the ARCAD Database.

J Clin Oncol 2016 Jan 26;34(2):144-50. Epub 2015 Oct 26.

Lindsay A. Renfro and Daniel J. Sargent, Mayo Clinic, Rochester, MN; Fotios Loupakis and Alfredo Falcone, Azienda Ospedaliero-Universitaria Pisana and Università di Pisa, Pisa, Italy; Richard Adams, Cardiff University, Cardiff; Matthew T. Seymour, St James's Hospital and University of Leeds, Leeds, United Kingdom; Volker Heinemann, University of Munich, Munich; Hans-Joachim Schmoll, University Clinic Halle (Saale), Halle; Rainer Porschen, Klinikum Bremen-Ost Klinik für Innere Medizin, Bremen; Carsten Bokemeyer, University Hospital Cancer Center, University Hospital, Hamburg-Eppendorf, Germany; Jean-Yves Douillard, Institut de Cancerologie, Centre René Gauducheau, Nantes; Christophe Tournigand, University of Paris Est Creteil, Henri-Mondor Hospital, Créteil; Benoist Chibaudel and Aimery de Gramont, Franco-British Institute, Levallois-Perret, France; Herbert Hurwitz, Duke University Medical Center, Durham, NC; Charles S. Fuchs, Dana-Farber Cancer Institute Boston, MA; Eduardo Diaz-Rubio, Instituto de Investigación Sanitaria del Hospital Clínico San Carlos, Madrid, Spain; Niall C. Tebbutt, Austin Health, Heidelberg, Victoria, Australia; Cornelis J.A. Punt, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands; J. Randolph Hecht, David Geffen School of Medicine at the University of California at Los Angeles; Heinz-Josef Lenz, University of Southern California/Norris Comprehensive Cancer Center, Keck School of Medicine, Los Angeles, CA; Eric Van Cutsem, University Hospital Leuven, Leuven, Belgium; Richard M. Goldberg, Ohio State University, Columbus, OH; and Leonard B. Saltz, Memorial Sloan-Kettering Cancer Center, New York, NY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.61.6441DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5070548PMC
January 2016

Adjuvant Fluorouracil, Leucovorin, and Oxaliplatin in Stage II to III Colon Cancer: Updated 10-Year Survival and Outcomes According to BRAF Mutation and Mismatch Repair Status of the MOSAIC Study.

J Clin Oncol 2015 Dec 2;33(35):4176-87. Epub 2015 Nov 2.

Thierry André and Jean-François Fléjou, Hôpital St Antoine; Thierry André and Jean-François Fléjou, University Pierre et Marie Curie Paris VI; Thierry André, Benoist Chibaudel, Annemilaï Tijeras-Raballand, Soudhir Colote, and Aimery de Gramont, Groupe Coopérateur Multdisciplinaire en Ocologie (GERCOR) Oncology Multidisciplinary Group and GERCOR-Innovative Research Consortium; Christophe Louvet, Institut Mutualiste Montsouris; Alex Duval, L'Institut National de la Santé et de la Recherche Médicale UMRS 938, Paris; Armand de Gramont, Benoist Chibaudel, Annemilaï, Tijeras Raballand, Aurelie Scriva, and Aimery de Gramont, Institut Hospitalier Franco Britannique, Levallois-Perret; Dewi Vernerey and Franck Bonnetain, Hôpital Saint-Jacques, Besançon; Christophe Tournigand, Hôpital Henri Mondor, Créteil, France; Armand de Gramont, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland; Tamas Hickish, Dorset Bournemouth University, Dorset, United Kingdom; Josep Tabernero and Stefania Landolfi, Vall d'Hebron University Hospital and Institute of Oncology, Barcelona; Josep Tabernero, TTD Group, Madrid, Spain; Jean Luc Van Laethem and Pieter Demetter, Hôpital Universitaire Erasme, Brussels, Belgium; Maria Banzi, Arcispedale Santa Maria Nuova, Reggio, Italy; Eduard Maartense, Reinier de Graaf Groep, Delft, the Netherlands; Einat Shmueli, Sheba Medical Center, Tel Hashomer, Israel; Goran U. Carlsson, Sahlgrenska University Hospital, Östra, Sweden; Werner Scheithauer, Medical University of Vienna, Vienna, Austria; Demetris Papamichael, B.O. Cyprus Oncology Centre, Nicosia, Cyprus; and Marcus Möehler, University Medical Center of the Johannes Gutenberg University of Mainz, Mainz, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.63.4238DOI Listing
December 2015

Maintenance treatment in metastatic colorectal cancer.

Lancet Oncol 2015 Dec;16(16):e583-4

Department of Medical Oncology, Institut Hospitalier Franco-Britannique, 92300 Levallois-Perret, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1470-2045(15)00448-9DOI Listing
December 2015

[DNA mismatch repair and BRAF status in colorectal cancer: Interest for the therapeutic management?].

Bull Cancer 2015 Jun;102(6 Suppl 1):S72-81

Service d'oncologie médicale, Hôpitaux universitaires de l'Est Parisien (AP-HP), Site Saint-Antoine 184, rue du Faubourg Saint-Antoine, 75571 Paris cedex 12, France; Université Pierre et Marie Curie (UPMC), Paris VI, Paris, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S0007-4551(15)31220-0DOI Listing
June 2015

Therapeutic strategy in unresectable metastatic colorectal cancer: an updated review.

Ther Adv Med Oncol 2015 May;7(3):153-69

Department of Medical Oncology, Institut Hospitalier Franco-Britannique, Levallois-Perret, France and GERCOR, Groupe Coopérateur Multidisciplinaire en Oncologie, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1758834015572343DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4406914PMC
May 2015

Pragmatic issues in biomarker evaluation for targeted therapies in cancer.

Nat Rev Clin Oncol 2015 Apr 25;12(4):197-212. Epub 2014 Nov 25.

Division of Pathology and Laboratory Medicine, University of Texas MD Anderson Cancer Center, USA.

View Article

Download full-text PDF

Source
http://www.nature.com/articles/nrclinonc.2014.202
Publisher Site
http://dx.doi.org/10.1038/nrclinonc.2014.202DOI Listing
April 2015

Feasibility and survival of 2-stage hepatectomy for colorectal metastases: definition of a simple and early clinicopathologic predicting score.

Surgery 2015 Mar 6;157(3):444-53. Epub 2014 Nov 6.

Departments of Hepatobiliary Surgery and Liver Transplantation, Hôpital Saint Antoine, Paris, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.surg.2014.09.033DOI Listing
March 2015

Individual patient data analysis of progression-free survival versus overall survival as a first-line end point for metastatic colorectal cancer in modern randomized trials: findings from the analysis and research in cancers of the digestive system database.

J Clin Oncol 2015 Jan 10;33(1):22-8. Epub 2014 Nov 10.

Qian Shi, Axel Grothey, and Daniel J. Sargent, Mayo Clinic, Rochester, MN; Aimery de Gramont and Benoist Chibaudel, Hospital Saint Antoine; Christophe Tournigand, Université Paris Est Créteil, Paris; Jean-Yves Douillard, Institute of Cancer Research in Western, St Herblain, France; John Zalcberg, Monash University; Niall C. Tebbutt, Austin Health, Melbourne, Victoria, Australia; Hans-Joachim Schmoll, Martin-Luther University, Halle; Rainer Porschen, Klinikum Bremen-Ost, Bremen; Volker Heinemann, University of Munich, München; Carsten Bokemeyer, University Hospital, Hamburg-Eppendorf, Germany; Matthew T. Seymour, Cancer Research UK Clincal Center, Leeds; Richard Adams, Cardiff University, Cardiff, United Kingdom; Leonard Saltz, Memorial Sloan-Kettering Cancer Center, New York, NY; Richard M. Goldberg, Ohio State University, Columbus, OH; Cornelis J.A. Punt, Academic Medical Center, Amsterdam, the Netherlands; Paulo M. Hoff, Hospital Sírio-Libanês, Sao Paulo, Brazil; Joel Randolph Hecht and Fairooz F. Kabbinavar, University of California at Los Angeles, Los Angeles, CA; Herbert Hurwitz, Duke University, Durham, NC; Eduardo Díaz-Rubio, Hospital Clinico San Carlos, Madrid, Spain; Charles Fuchs, Dana-Farber Cancer Institute, Boston, MA; John Souglakos, University of Crete, Heraklion, Greece; Alfredo Falcone, University of Pisa, Pisa, Italy; Eric Van Cutsem, University Hospital Gasthuisberg, Leuven; and Marc Buyse, International Drug Development Institute, Louvain-la-Neuve, Belgium.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2014.56.5887DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4482837PMC
January 2015

Impact of preoperative and postoperative FOLFOX chemotherapies in patients with resectable colorectal liver metastasis.

J Gastrointest Cancer 2014 Sep;45(3):298-306

Department of Digestive Surgery, AP-HP Hôpital Saint Antoine, 184, rue du Faubourg Saint Antoine, Paris, 75012, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12029-014-9594-yDOI Listing
September 2014

Intrinsic bevacizumab resistance is associated with prolonged activation of autocrine VEGF signaling and hypoxia tolerance in colorectal cancer cells and can be overcome by nintedanib, a small molecule angiokinase inhibitor.

Oncotarget 2014 Jul;5(13):4709-21

Cancer Biology and Therapeutics, Centre de Recherche Saint-Antoine; Institut National de la Santé et de la Recherche Médicale U938, Paris, France; Université Pierre et Marie Curie, Paris, France.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4148093PMC
http://dx.doi.org/10.18632/oncotarget.1671DOI Listing
July 2014

Platinum-sensitivity in metastatic colorectal cancer: towards a definition.

Eur J Cancer 2013 Dec 3;49(18):3813-20. Epub 2013 Sep 3.

Department of Medical Oncology, Hôpital Saint Antoine, APHP, Paris, France; Université Pierre et Marie Curie, Université Paris 6, Paris, France; GERCOR, Groupe Coopérateur Multidisciplinaire en Oncologie, Paris, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2013.07.150DOI Listing
December 2013

Regorafenib for metastatic colorectal cancer.

Lancet 2013 May;381(9877):1536-7

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S0140-6736(13)60975-7DOI Listing
May 2013

Disease-free survival in colon cancer: still relevant after all these years!

J Clin Oncol 2013 Apr 18;31(12):1609-10. Epub 2013 Mar 18.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2012.47.4452DOI Listing
April 2013

Squamous-cell carcinoma of the anal canal: room for improvement with targeted therapy.

Clin Res Hepatol Gastroenterol 2012 Jun 3;36(3):209-13. Epub 2011 Dec 3.

Instituto do Cancer do Estado de São Paulo, 251 avenida Doutor Arnaldo, 01246-000 São Paulo, Brazil.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clinre.2011.10.008DOI Listing
June 2012

The ARCAD clinical trials program: an update and invitation.

Oncologist 2012 2;17(2):188-91. Epub 2012 Feb 2.

Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, Minnesota, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2011-0332DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3286167PMC
June 2012

A man with colon cancer and tonsil swelling. Tonsillar metastasis from colon cancer.

Gastroenterology 2012 Jun 24;142(7):1423, 1625. Epub 2012 Apr 24.

Service d'Oncologie Médicale, Hôpital Saint-Antoine, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.gastro.2012.01.002DOI Listing
June 2012

[Adjuvant bevacizumab and cetuximab for stage III colon cancer: why such failure in an adjuvant situation?].

Bull Cancer 2012 Jun;99(6):607-8

Université Pierre-et-Marie-Curie, Assistance publique-Hôpitaux de Paris, hôpital Saint-Antoine, service d’oncologie médicale, Inserm U938, 184, rue du Faubourg-Saint-Antoine, 75571 Paris Cedex 12, France.

View Article

Download full-text PDF

Source
June 2012

Therapeutic strategy in unresectable metastatic colorectal cancer.

Ther Adv Med Oncol 2012 Mar;4(2):75-89

Division of Medical Oncology, Hôpital Saint-Antoine, Assistance Publique des Hôpitaux de Paris, 184 rue du faubourg Saint-Antoine, 75571, Paris Cedex 12, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1758834011431592DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3296081PMC
March 2012

The evolution of adjuvant therapy in the treatment of early-stage colon cancer.

Clin Colorectal Cancer 2011 Dec;10(4):218-26

Service d'Oncologie médicale, Hôpital Saint-Antoine, Assistance Publique des Hôpitaux de Paris, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clcc.2011.10.001DOI Listing
December 2011

Chemotherapy: Is adjuvant chemotherapy an option for stage II colon cancer?

Nat Rev Clin Oncol 2011 Sep 13;8(10):574-6. Epub 2011 Sep 13.

View Article

Download full-text PDF

Source
http://www.nature.com/articles/nrclinonc.2011.139
Publisher Site
http://dx.doi.org/10.1038/nrclinonc.2011.139DOI Listing
September 2011

Re-challenge and the concept of lines of therapy in metastatic colorectal cancer.

Eur J Cancer 2011 Sep;47 Suppl 3:S76-84

Hôpital Saint-Antoine, APHP, Universite Paris VI, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S0959-8049(11)70150-2DOI Listing
September 2011

From chemotherapy to targeted therapy in adjuvant treatment for stage III colon cancer.

Semin Oncol 2011 Aug;38(4):521-32

Service d'Oncologie médicale, Hôpital Saint-Antoine, Assistance Publique des Hôpitaux de Paris, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.seminoncol.2011.05.006DOI Listing
August 2011

Integrating biomarkers in clinical trials.

Expert Rev Mol Diagn 2011 Mar;11(2):171-82

International Institute for Drug Development, 30 Avenue Provinciale, 1340 Louvain-la-Neuve, Belgium.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/erm.10.120DOI Listing
March 2011

Targeted therapies as adjuvant treatment for early-stage colorectal cancer: first impressions and clinical questions.

Clin Colorectal Cancer 2010 Dec;9(5):269-73

Service d'Oncologie Médicale, Hôpital Saint-Antoine, Assistance Publique des Hôpitaux de Paris, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3816/CCC.2010.n.039DOI Listing
December 2010

[Colorectal cancer. How to decrease mortality by two?].

Rev Prat 2010 Oct;60(8):1059-61

Service d'oncologie médicale, Hôpital Saint-Antoine, AP-HP, 75571 Paris Cedex 12.

View Article

Download full-text PDF

Source
October 2010

[Operable colon cancer: initial strategy].

Rev Prat 2010 Oct;60(8):1089-93

Service d'hépato-gastro-entérologie, Groupe hospitalier La Pitié-Salpêtrière, AP-HP, 75651 Paris Cedex 13.

View Article

Download full-text PDF

Source
October 2010

[Management of metastatic colorectal cancer].

Rev Prat 2010 Oct;60(8):1103-7

Service d'oncologie médicale, hôpital Saint-Antoine, 75571 Paris Cedex 12.

View Article

Download full-text PDF

Source
October 2010

Stage II and stage III colon cancer: treatment advances and future directions.

Cancer J 2010 May-Jun;16(3):202-9

Service d'Oncologie Médicale, Hôpital Saint-Antoine, Assistance Publique des Hôpitaux de Paris, France.

View Article

Download full-text PDF

Source
https://insights.ovid.com/crossref?an=00130404-201005000-000
Publisher Site
http://dx.doi.org/10.1097/PPO.0b013e3181ddc5bfDOI Listing
September 2010

Biomarkers and surrogate end points--the challenge of statistical validation.

Nat Rev Clin Oncol 2010 Jun 6;7(6):309-17. Epub 2010 Apr 6.

International Drug Development Institute, 30 Avenue Provinciale, 1340 Louvain-la-Neuve, Belgium.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nrclinonc.2010.43DOI Listing
June 2010

Toward efficient trials in colorectal cancer: the ARCAD Clinical Trials Program.

J Clin Oncol 2010 Feb 19;28(4):527-30. Epub 2009 Oct 19.

Hôpital Saint Antoine, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2009.25.2544DOI Listing
February 2010

Integration of neoadjuvant and adjuvant chemotherapy in patients with resectable liver metastases from colorectal cancer.

Cancer Treat Rev 2009 Dec 5;35(8):668-75. Epub 2009 Sep 5.

Department of Medical Oncology, University Hospital, Lille, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ctrv.2009.08.005DOI Listing
December 2009

Accomplishments in 2008 in the adjuvant treatment of colon cancer.

Gastrointest Cancer Res 2009 Sep;3(5 Supplement 2):S2-7

Division of Hematology/Oncology, Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2791381PMC
September 2009

Accomplishments in 2007 in the adjuvant treatment of colorectal cancer.

Gastrointest Cancer Res 2008 May;2(3 Suppl):S2-6

Department of Medical Oncology, Hôpital Saint-Antoine, Paris, France.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2664907PMC
May 2008

Accomplishments in gastrointestinal oncology in 2007: conclusion.

Gastrointest Cancer Res 2008 May;2(3 Suppl):S57

Department of Medical Oncology, Hôpital Saint-Antoine, Paris, France.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2664913PMC
May 2008